RU2005140097A - Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний - Google Patents

Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний Download PDF

Info

Publication number
RU2005140097A
RU2005140097A RU2005140097/15A RU2005140097A RU2005140097A RU 2005140097 A RU2005140097 A RU 2005140097A RU 2005140097/15 A RU2005140097/15 A RU 2005140097/15A RU 2005140097 A RU2005140097 A RU 2005140097A RU 2005140097 A RU2005140097 A RU 2005140097A
Authority
RU
Russia
Prior art keywords
surfactants
polydimethylsiloxane
microns
amphoteric
proportion
Prior art date
Application number
RU2005140097/15A
Other languages
English (en)
Russian (ru)
Inventor
Герд ТЕНЕ (DE)
Герд ТЕНЕ
Original Assignee
БАУЭР, Вульф (DE)
БАУЭР, Вульф
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by БАУЭР, Вульф (DE), БАУЭР, Вульф filed Critical БАУЭР, Вульф (DE)
Publication of RU2005140097A publication Critical patent/RU2005140097A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/80Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2005140097/15A 2003-05-22 2004-05-19 Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний RU2005140097A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10323758A DE10323758A1 (de) 2003-05-22 2003-05-22 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen
DE10323758.5 2003-05-22

Publications (1)

Publication Number Publication Date
RU2005140097A true RU2005140097A (ru) 2006-08-10

Family

ID=33441299

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005140097/15A RU2005140097A (ru) 2003-05-22 2004-05-19 Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний

Country Status (9)

Country Link
US (1) US20070172435A1 (enExample)
EP (1) EP1635849A1 (enExample)
JP (1) JP2006528211A (enExample)
CN (1) CN1795001A (enExample)
AU (1) AU2004243524A1 (enExample)
CA (1) CA2526175A1 (enExample)
DE (1) DE10323758A1 (enExample)
RU (1) RU2005140097A (enExample)
WO (1) WO2004105776A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10323759A1 (de) * 2003-05-22 2004-12-16 Bauer, Wulf, Dr. Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen
BE1018537A3 (fr) 2007-09-13 2011-03-01 Basf Se Procede d'exploitation d'une separation en continu d'un produit cible x sous la forme d'un cristallisat finement divise.
DE102007043748A1 (de) 2007-09-13 2008-09-11 Basf Se Verfahren zur kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat
DE102007043758A1 (de) 2007-09-13 2008-10-23 Basf Se Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat des Zielproduktes X
DE102007043759A1 (de) 2007-09-13 2008-09-11 Basf Se Verfahren zum Betreiben einer kontinuierlichen Abtrennung eines Zielproduktes X in Form von feinteiligem Kristallisat
DE102010030279A1 (de) 2010-06-18 2010-10-28 Basf Se Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge
US8461383B2 (en) 2009-10-16 2013-06-11 Basf Se Process for starting up a separating process for purifying removal of acrylic acid crystals from a suspension S of crystals thereof in mother liquor
DE102009045767A1 (de) 2009-10-16 2010-08-12 Basf Se Verfahren der Inbetriebnahme eines Trennverfahrens zur reinigenden Abtrennung von Acrylsäurekristallen aus einer Suspension S ihrer Kristalle in Mutterlauge
US10398727B2 (en) 2014-11-24 2019-09-03 University Of Technology, Sydney Methods for the treatment and prevention of asbestos-related diseases
CN104606261B (zh) * 2015-03-05 2018-02-09 潘友长 一种沸石药物组合物及其制备方法和用途
CN105837734A (zh) * 2016-05-09 2016-08-10 上海惠昌化工厂 有机硅改性丙烯酸聚酯钾盐及制备方法和防癌治癌用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310572A (en) * 1987-02-03 1994-05-10 Dow Corning Corporation Process for forming a coated active agent-containing article
US5418220A (en) * 1994-03-08 1995-05-23 Schmidt; Alfred Method for treating constipation using dimethicone
US5587149A (en) * 1995-02-06 1996-12-24 R.P. Scherer Corporation Topical application emulsions
DE59707063D1 (de) * 1996-03-25 2002-05-23 Bauer Wulf Heilmittel zur äusserlichen anwendung und verwendung einer wässrigen öl-emulsion für ein derartiges heilmittel
US6347408B1 (en) * 1998-11-05 2002-02-19 Allegiance Corporation Powder-free gloves having a coating containing cross-linked polyurethane and silicone and method of making the same
EP1107826A1 (de) * 1999-04-26 2001-06-20 Tihomir Lelas Vorrichtung zum mikronisieren von materialien

Also Published As

Publication number Publication date
EP1635849A1 (de) 2006-03-22
WO2004105776A1 (de) 2004-12-09
CN1795001A (zh) 2006-06-28
AU2004243524A1 (en) 2004-12-09
CA2526175A1 (en) 2004-12-09
JP2006528211A (ja) 2006-12-14
US20070172435A1 (en) 2007-07-26
DE10323758A1 (de) 2004-12-16

Similar Documents

Publication Publication Date Title
GEP20063741B (en) Nonaryl-Heterocyclic NMDA/NR2B Antagonists
WO2007054279A8 (en) Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions
EP2182006A3 (en) Compositions and methods for the treatment of immune related diseases
MXPA05008368A (es) 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
IL207468A (en) HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections
EP2213684A3 (en) Nogo-a antibodies for the treatment of Alzheimer disease
TW200716631A (en) Pyrido[2,3-d]pyrimidines useful as HCV inhibitors, and methods for the preparation thereof
RU2005140097A (ru) Лекарственное средство для внутреннего применения, в частности, против раковых заболеваний
EA200800064A1 (ru) Композиция в виде гранул с модифицированным и немедленным высвобождением мемантина
EP2322201A3 (en) Compositions and methods for the treatment of immune related diseases
WO2007100366A3 (en) Quinolone m1 receptor positive allosteric modulators
WO2007041487A3 (en) Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family
EP1423137A4 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP4039688A3 (en) Substituted pyrrolopyrimidine and pyrazolopyrimidine as bruton's tyrosine kinase (btk) degraders
IL171914A0 (en) Variants of il-18bp, their preparation and pharmaceutical compositions containing them
TW201129386A (en) Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients
WO2009151498A3 (en) Memantine formulations
EA200801411A1 (ru) Новые адъюванты на основе конъюгатов и производных бис-ацилоксипропилцистеина и их применения в фармацевтических композициях
HK1079984A1 (zh) 抑制hiv复制的甘氨酰胺衍生物
MXPA01008613A (es) Epitopos o mimotopos derivados del dominio c-epsilon-2 de ige, antagonistas de los mismos y sus usos terapeuticos.
WO2006041843A3 (en) Pharmaceutical dosage form comprising meloxicam
GB0123276D0 (en) Uses of agents that bind immune-system components
IT1317905B1 (it) Varianti di allergeni ns-ltps, loro usi e composizioni che lecomprendono.
MXPA05007495A (es) Tienopiridazinonas y su uso en la modulacion de enfermedades autoinmunes.
GEP20043301B (en) Heterocyclic Amide Derivatives, Pharmaceutical Compositions Containing the Same and Use Thereof for Treatment of Inflammation and Other Immune Disorders